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1. Introduction 
The molecular basis of embryo-maternal relationship, that leads to proper implantation into 
a receptive maternal endometrium to successfully establish a pregnancy, is still not fully 
understood. The human endometrium undergoes morphological and hormonal changes 
during the menstrual cycle in preparation for successful embryo implantation, or menstrual 
shedding in the absence of implantation. The success of implantation process depends on a 
receptive endometrium, a blastocyst quality as well as  embryo-endometrial interface 
synchronization. Only 5% of collected oocytes and only 20-25% of transferred embryos can 
lead to a birth of a healthy newborn. 
How can we improve implantation rate following infertility treatment? Two main 
hypotheses can be put forward as a solution: 
1. Patient-determined embryo quality, 
2. Endometrial quality: patient-determined or a results of a synchronous steroid hormone 
preparation.  
The discussion on these hypotheses will be presented in the following issues of this chapter. 
2. Embryo quality 
Since the in vitro fertilization (IVF) procedure was involved to Assisted Reproductive 
Technology (ART), there are lots of efforts trying to improve the IVF outcomes. At the 
beginning, the higher pregnancy rates observed in IVF cycles than in natural, were obtained 
by stimulating the growth of more than only one follicle as well as by transferring to the 
uterus excessive numbers of embryos. It has been led to negative side effect as multiple 
pregnancy, which is nowadays considered as a complication of infertility treatment. The 
quality of embryos seems to be the basic determinants of success for embryo implantation in 
the natural as well as in the stimulated cycles. The most important challenge in ART 
nowadays is the ability to identify the embryos with the greatest development potential. 
These embryos should be selected and transferred to the uterus. 
Some studies have supported the idea that only embryo quality is the best predictive factor 
for pregnancy in IVF cycles (Brezinova et al.,2009; Fauque et al.,2007), significantly better 
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than the assessment of endometrial features (Terriou et al.,2007; Terriou et al.,2001; Zhang et 
al.,2005). Some of them present results showing the relations between endometrial features 
and IVF outcomes analysed at different stages of embryo development. 
There are lots of methods for evaluating embryo implantation potential and correlations 
between  characteristics of follicles, the oocytes, the zygotes, the early cleavage embryos, the 
morulas and blastocysts. The ideal method for embryo selection should be non-invasive, 
easy to assess, standardized, with correlation to pregnancy outcomes. 
The studies concerning the determination of new methods for assessing embryos using 
metabolomics, proteonomics and genomics are still pending, and their results are not yet 
clinically applicable. Most laboratories still use morphological criteria for embryo 
assessment. The assessment of embryo morphology is the most important part of many 
embryo scoring systems. Morphological characteristics provide a lot of information about 
regular or irregular embryo development, but also present many limitations. They cannot 
detect genetic disorders of gametes or embryos, and either predict normal pregnancy 
outcome. 
In natural cycles fertilization of oocyte and early cleavage embryo development have place 
in fallopian tube and then blastocyst is transferred to the uterus where it is implanted in 
uterine endometrium. In the IVF cycles the early embryo development from zygote to 
blastocyst can be observed in lab conditions, where the analysis of morphological 
characteristic is allowed. 
2.1 Zygote scoring systems 
The most important predicting factor of normal embryo development in the zygote stage is 
the visualization of two pronuclei (PNs), one from sperm cell and one from oocyte. It should 
occur between 16 and 19 hour after fertilization. In the past, 5 grade zygote scoring system 
presented by Scott et al. (Scott et al.,2000) was based on five zygote features: PNs size, the 
nuclear alignment, the nucleolar alignment and the distributions, and the position. Grade 1 
was described as equal number of nucleoli aligned at the pronuclear junction. Grade 2 - as 
an equal number of nucleoli in equal size in the same nuclei, and one of nuclei having 
alignment at the pronuclear junction, and the second one with scattered nucleoli. Grade 3 
was described as equal numbers of nucleoli in equal size equally scattered in the two nuclei. 
Grade 4 – unequal numbers of nucleoli and/or unequal size. Grade 5 – with not aligned 
pronuclei, in different size, and not placed in the central part of zygote. This system was 
then modified by author to the 4 grades Z score system. The following parameters which 
were assessed: PNs size and alignment, aligment of nucleoli within the PNs and cytoplasmic 
morphology. The total number of points which could be achieved was ranged between 3 
and 35. Embryos with more than 15 points were classified as embryos with the highest 
implantation potential, and presented about 70% pregnancy rate (Scott et al.,2000; Scott & 
Smith,1998). 
The last modification of Z score system was proposed in 2003 by Scott (Scott,2003). The 
scoring system was based on the zygotes features that can be observed at the time of 
fertilization. The last version has been commonly used by many labs. In comparison to the 
previous version the presence of halo was associated with better morphology of embryos 
assessed in the 3rd  and the 5th  day of their development. Zygotes assessed as Z1 and Z2 had 
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the highest implantation rate. The Z1 and Z2 zygotes presented significantly higher number 
of good quality blastocysts on the 5th day after fertilization. All pregnancies from day 5 
transfers resulted from the transfer of blastocysts that originated from Z1 or Z2 zygotes. 
Figure 1 shows comparison the 5 grade score with Z zygote scoring system. 
 
Fig. 1. The 5 grade score and Z zygote scoring systems. 
There are some studies that evaluate the usefulness of cumulative zygote scoring systems on 
embryo implantation. Ludwig et al. (Ludwig et al.,2000) presented modified Scott’s Z score 
system, where the threshold for positive IVF results was 13 points. Embryos presented less 
than 13 points according to the Z score system presented negative implantation results in 
92%. Zollner et al. (Zollner et al.,2002) created the cumulative zygote scoring system similar 
to the Z score system. The following features of zygote were used to evaluate zygote quality: 
www.intechopen.com
 The Human Embryo 
 
40
number, the position and size of pronuclei, the alignment and the number of nucleoli in 
each pronuclei,  halo effect, morphology of vacuoles and structure of cytoplasm. The 
zygotes with more than 15 points were associated with higher quality of blastocyst in the 5th 
day of embryo development. 
Another zygote scoring system was proposed by Tesarik and Greco (Tesarik & Greco,1999). 
They created the system based on the assessment of the number and distribution of each 
PN. The system divide embryos into 2 groups: pattern 0 and non pattern 0. Its allows 
efficient prediction of implantation rate using static, single observation of zygote’s state. 
Authors reported 30% implantation rate among pattern 0 embryos, and 11% among non 
pattern 0 embryos. 
The assessment of zygote morphology at 16 and 19 hour after fertilization seems to be 
helpful in selection of the embryos with the highest potential for implantation. The 
evaluation of zygote morphology seems to be helpful in countries with internal law 
regulations imposing embryo selection at the PNs stage. This scoring systems can be used in 
patients who would have benefited from the 5th day embryo transfer (ET), especially in 
countries where the high costs of ART techniques exist parallel with the poor, not optimal 
embryo culture systems. 
 
Fig. 2. Abnormalities of zygote stage embryos: A – mononucleation (1PN); B – vacuoles in 
cytoplasm; C – dysmorphic zygote (2PNs); D – multinucleation (3PNs). 
2.2 Cleavage embryos scoring systems 
Twenty five hours after the fertilization embryos reach 2-cell stage of their development. 
There are very few studies focusing on this stage and on its impact on the positive 
implantation. Most of them (Ciray,2007; Ciray et al.,2004) presented the conclusions that 
assessment of 2-cell embryo stage together with the subsequent stages of embryo 
development can present additive positive value in embryo reproductive potential and 
implantation rate. 
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Fig. 3. Good quality early cleavage embryos: A - 2 blastomer stage; B - 4 blastomer stage. 
The perfect 4-cell embryo should have equal size of regular symmetrical blastomers with 
minimal fragmentation (Giorgetti et al.,2007; Terriou et al.,2007). Nowadays, the nucleation 
of blastomers has important value in selection of abnormal embryos. Multinucleated 
blastomers are associated with lower implantation rate due to the high risk of chromosomal 
abnormalities. Mononucleation of all 4 blastomers is associated with higher embryo 
reproductive potential (Saldeen & Sundstrom,2005). 
 
Fig. 4. Abnormalities of early cleavage embryos: A – defect of zona pellucida; B - irregular 
size of blastomers; C – dysmorphic 2 blastomer embryo; D – shrink blastomers; E – thick 
zona pellucida; F – total cytoplasm defragmentation. 
On the third day after fertilization 8-cell stage of embryo development should be confirmed. 
The assessment of three day embryo includes the number of cells, the symmetry of 
blastomers, the degree of fragmentation, and eventually the early embryo compaction. 
Many studies confirmed the relationship between the number of blastomers observed on the 
third day after fertilization and implantation rate following transfer taking place on this day. 
Some authors suggest that embryos having exactly 8 blastomers on the third day present the 
highest reproductive potential. These embryos have the highest implantation rate 
(Racowsky et al.,2003). 
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Fig. 5. Good quality cleavage stage: A - 8 blastomer stage; B – 6 blastomer stage. 
Another study showed that at least 8 or more blastomers observed in the third day of 
embryo development were associated with higher implantation rate in comparison to less 
than 8 cells (Carrillo et al.,1998). Other authors maintained that 7 to 9 blastomers observed 
on the third day was connected with the highest implantation potential (Alikani et al.,2000). 
 
Fig. 6. Abnormalities of cleavage embryos: A – dysmorphic embryo; B – vacuole into one of 
blastomers; C – thick zona pellucida; D -  total cytoplasm defragmentation. 
The percentage of fragmentation is still under discussion by many authors. The minimal 
fragmentation and symmetry of blastomers positively correlate with implantation rate 
similar to the 4-cell stage embryos. There are few studies that present that the early 
visualization of embryo compaction on the third day of embryo development is a positive 
prognostic factor for further embryo implantation. In at least 8-blastomer embryos with 
minimal fragmentation, early compaction was associated with higher implantation rate 
(Skiadas et al.,2006). Desai et al. (Desai et al.,2000) suggested that to assess reproductive 
potential of 3 day embryo, the following features should be taken under consideration: 
number, size and the symmetry of blastomers; compaction; the grade of fragmentation; 
vacuoles in cytoplasm; blastomer expansion. The evaluation of this characteristics was 
connected with more than 80% sensitivity in prediction of positive implantation. 
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2.3 Blastocyst scoring systems 
The progress in ART techniques, especially in culture media and metabolimics, allow longer 
incubation of embryos in lab conditions and their development to blastocyst stage. The 
transfer of blastocyst imitates the natural conception cycles, where such “embryo-uterine 
dialogue” is responsible for creation of a new life. Similar to the cleavage stage embryos, 
embryo morphological features are very important in assessment of blastocyst quality and 
its reproductive potential. Most of blastocyst scoring systems are based on evaluation 
embryo morphology and are focused on: blastocyst development stage - expansion and 
hatching status, inner cell mass (ICM)  quality; trophoectoderm (TE) quality. The blastocyst 
stage is usually reached on the fifth day of embryo development. One of the most common 
used blastocyst scoring system was proposed by Gardner (Gardner et al.,2000). 
Blastocysts are named using numerical score from 1 to 6 according to their expansion and 
hatching status: 
1. Early blastocyst, blastocoel cavity less than half the volume of the embryo 
2. Blastocoel cavity more than half the volume of the embryo 
3. Full blastocyst, cavity completely fills the embryo 
4. Expanded blastocyst, cavity larger than the embryo, with thinning of the zona 
5. Hatching blastocyst, the trophoectoderm has started to harniate through the zona 
6. Hatched blastocyst, has completely escaped from the zona 
The blastocyst are also assessed according to ICM quality: 
a. Many cells, tightly packed 
b. Several cells, loosely grouped 
c. Very few cells 
As well as according to TE quality: 
a. Many cells, forming a cohesive layer 
b. Few cells, forming a loose epithelium 
c. Very few large cells 
Blastocysts are given a quality grade for each of the 3 components and the score is expressed 
with the expansion grade listed first, the inner cell mass grade listed second and the 
trophectoderm grade third. For example, a blastocyst quality grade of 4AA means that the 
blastocoel cavity is expanding and the zona is thinning (grade 4), it has many tightly packed 
cells in the inner cell mass (grade A), and has a trophectoderm  can be seen to be composed 
of numerous cells (grade A). 
 
Fig. 7. Good quality blastocysts: A - good quality expanded blastocyst (4AA); B – hatching 
blastocyst (5AA). 
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Another scoring system was proposed by Dokras et al. (Dokras et al.,1993). The blastocyst 
grading according to following schema is presented as: grade 1 blastocysts with early 
cavitation resulting in the formation of an eccentric and then expanded cavity lined by a 
distinct ICM region and TE layer; grade 2 blastocyst exhibited a transitional phase where 
single or multiple vacuoles were seen that over subsequent days developed into the typical 
blastocyst appearance of the grade 1 blastocysts; grade 3 - blastocysts with several 
degenerative foci in the ICM with necrotic cells. The Dokras system is mainly based on 
embryo developmental potential and expansion of the blastoceol cavity. The Gardner’s 
system is more detailed than Dokras system, taking into account the appearance of ICM and 
TE quality. Balaban et al. (Balaban et al., 2006) in randomized trial compared both scoring 
systems, and observed the better outcome in the Gardner system, where higher 
implantation rates were observed. Gardner’s system offers higher selective criteria for the 
blastocysts, which in turn is reflected in the clinical outcome following embryo transfer. 
Rehman et al. (Rehman et al., 2007) presented a numerical blastocyst-morphology grading 
system (blastocyst quality score BQS). This system correlate with criteria established by 
Gardner. BQS is defined as the product of degree of expansion and hatching status and ICM 
and TE grades, where letter grade A is given the value 3, grade B –value 2, and grade C – 
value 1. For example BQS calculation for a 4AB blastocyst is 4x3x2, with a BQS of 24 points. 
The authors calculate each Gardner’s scale score with BQS. Authors tried to present a 
possible correlation between BQS and number of cells in the blastocysts, but they did not 
present the number of cells in studied blastocysts. Although Gardner’s blastocyst 
morphology grading system is clinically useful scheme and has been shown to predict 
implantation rates, there are several limitations associated with the use of BQS in clinical 
practice. 
In the literature, there are few studies investigating the usefulness of cumulative, combined 
multiday embryo scoring systems in evaluation the embryo reproductive potential. The 
investigators tried to combine morphological characteristics of zygotes, cleavage stage 
embryos and blastocysts to improve the embryo selection process. Available data suggests 
that combined mulitiday embryo assessment provides many usefulness information about 
embryo development, than a single day scoring systems. However, there is no ideal 
multiday system which could be implemented to clinical practice nowadays. There have 
been still undetectable critical time points of embryo development which could provide 
accurate information about the ideal time for successful embryo transfer. 
More clinical trials are needed to find more accurate embryo selection parameters. Over the  
last few years, few continuous time lapse embryo monitoring systems were presented, as a 
device that can improve IVF outcomes by better embryo selection. Special incubators equipped 
with digital camera allows 24 hours observation of embryo incubation, from the conception till 
the time of transfer. Images of each embryo are automatically recorded at preset time intervals. 
Detailed information about timing of cell divisions and other critical events can provide future 
extensive documentation that embryologists can use to select a viable embryo for transfer 
during an IVF treatment. This method is reported as sufficiently safe. Constant embryo 
monitoring is performed inside incubators, so the embryos are never exposed to adverse 
growth conditions or temperatures. Images and detailed information about incubation 
conditions can be stored in patient data files for future reference. There is also an global idea 
for creation of the large database of embryo images (more than 20 million images) and a 
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detailed analysis of the development pattern of embryos that successfully implanted and 
resulted in ongoing clinical pregnancies compared to embryos that failed to implant. The 
prospective clinical trials are required to analyze the obtained data, which can contribute to 
creation of novel embryo selection procedures, and thus improve IVF outcomes. 
The optimum day for embryo transfer procedure seems to be established. Most of the recent 
studies suggest that  the ideal time for embryo transfer is blastocyst stage in the fifth day. 
Prolonged embryo culture and the availability of blastocysts for transfer are associated with 
increased implantation rate and better neonatal outcomes compared with 2 or 3 day 
transfers of cleavage embryo stages (Blake et al.,2007; Kallen et al.,2010; Gardner et al.,2000; 
Papanikolaou et al.,2006). Taking under consideration the high implantation rate of 
blastocyst, a single embryo transfer can be offered for selected patients, which tends to 
reduce the number of multiple pregnancies (Kawachiya et al.,2011; Papanikolaou et 
al.,2010). The transfer only one blastocyst in the first attempt may lead to higher cumulative 
pregnancy rate by allowing transfer remaining frozen blastocyst in the next cycle.  However, 
blastocyst transfer may not be ideal for all IVF patients, in all clinical situations. A Cochrane 
review of 16 trials on efficiency of blastocyst and day 3 embryo transfer, did not find the 
significant differences in pregnancy rate, miscarriages rate and multiple pregnancy. Some 
IVF canters still have problems with blastocyst culturing and/or freezing so the third day of 
transfer is an optimal solution in these cases. The problem of the optimal day of embryo 
transfer return back nowadays, and remains a significant element of discussion in many 
scientific societies working on reproductive medicine. 
 
Fig. 8. Abnormalities of 5 day embryos: A – dysmorphic morula; B – degenerating blastocyst 
before hatching; C – remained undeveloped blastomer in blastocyst. 
The assessment of just the embryo morphology cannot disclose, whether a particular 
embryo will be implanted or not, and it can not disclose all the information contained in the 
embryo. The most precise evaluation of the impact of embryo quality and endometrial 
features on the pregnancy rate should be carried out on patients with a single, high quality 
blastocyst transfer. The analysis of all the information obtained from the elective single 
embryo transfer procedures can help embryologist in the better embryo selection, leading to 
the improvement of implantation and pregnancy rates. The role of a single embryo transfer, 
the limitations of multiple embryo transfer, and the role of cryopreservation are still 
discussed nowadays. 
3. Growth factors and endometrial receptivity 
The estrogen dependent proliferative phase of the endometrium, which lasts from the 
menstrual bleeding until ovulation, is characterized by proliferation of endometrial glands 
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and endometrial stromal tissues as well as neoangiogenesis of endometrial blood vessels. 
The progesterone dependent secretory phase, which starts after ovulation with a peak of 
luteinizing hormone (LH) and ends with menstrual bleeding, is accompanied by high 
secretory activity of endometrial glands, elongation and growth of spiral arteries as well as 
decidualization of endometrial stroma. These all mechanisms enable embryonic invasion 
during the implantation window. Growth factors, cytokines and chemokines play an 
important role in paracrine and autocrine actions to affect the histologic and biochemical 
changes in endometrium before and during the implantation process. 
Communication between the embryonic and maternal tissues, while the embryo is 
transferred through the fallopian tube and in uterine cavity, seems to be an important factor 
in the successful embryo implantation. The embryo communicate with the maternal 
organism, by producing and secreting several cytokines, chemokines, growth factors during 
its development. 
At the time of implantation, according to increase the production of prostaglandins (mainly 
prostaglandin E2) in endometrium, the increase of capillary permeability in endometrial 
stroma is observed. By this time, secretory activity presents a peak, and endometrial cells 
becoming to be reach in lipids and glycogen. The window for endometrial receptivity is 
restricted to the 20th - 24th day in spontaneous 28-day regular cycle. Progesterone-induced 
formation of pinopodes (surface epithelial cells with smooth protrusions) appears on the 
endometrial surface. The pinopodes are able to absorb an intrauterine fluid trying to bring 
the blastocyst closer to their surface. Pinopodes appear around the 21st day of the cycle and 
exist only for a few days. After hatching the blastocyst from the zona pellucida, blastocyst 
adheres to the endometrial surface. During the last decade, the knowledge about 
communication between implanting blastocyst and maternal endometrium increased due to 
novel RNA and protein microarrays analyses. Without the presence of blastocyst, decidua 
synthesizes the factors that inhibiting the implantation process such: insulin-like growth 
factor binding protein-1 (IGFBP-1), tissue inhibitors of metalloproteinases (TIMPs). On the 
other site blastocyst promotes secretion the following factors counteracting maternal 
restraint mechanisms and promote embryo implantation into the endometrium: matrix 
metalloproteinases (MMPs), leukaemia inhibitory factor (LIF), epidermal growth factor 
(EGF), insulin like growth factor II (IGF II), and interleukins  (IL) (Giudice,2003). 
Trophoblast penetrates the uterine epithelial basement membrane by with use of some 
proteolytic enzymes, and finally implant in the endometrial stroma. Matrix 
metalloproteinases (MMPs) are the most important enzymes taking part in endometrial 
tissue reconstitution during implantation. MMPs degrade the extracellular matrix 
components as collagens, proteoglycans, glycoproteins. Among all the metelloproteinases, 
MMP-2 and MMP-9 seems to play the most important role in the tissue remodeling that 
accompanies implantation and decidualization. MMP-2 may participate in the early phase of 
decidual remodelling as well as in neoangiogenesis. MMP-9 can coordinate trophoblast 
invasion into the endometrial layer. Changes in the expression of these two 
metelloproteinases during implantation can occur without direct signals from the blastocyst. 
Some investigators indicate that the expression of these two metelloproteinases might be 
induced by some cytokines or growth factors, such as vascular endothelial growth factor 
(VEGF), transforming growth factor (TGF), epidermal growth factor (EGF) as well as by 
their specific tissue inhibitors (TIMPs) (Zhang et al.,2005). 
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There are studies suggesting the role of VEGF in endometrial neoangiogenesis during 
embryo implantation. Angiogenesis is a key process in preparation of endometrium for 
implantation. VEGF is a specific mitogen for endothelial cells that exerts its functions 
through two receptor tyrosine kinases (Flt-1 and Flk-1/KDR). These receptors were found in 
epithelial cells and stroma of endometrium. Neuropilin-1 (NRP-1), another receptor for 
VEGF, was found overexpressed in endometrium in the proliferative phase, in comparison 
to secretory phase of the cycle. Charnock-Jones et al. (Charnock-Jones et al.,1994) 
demonstrated that mRNA VEGF receptor, Flt-1, was overeexpressed in the cytotrophoblast 
and also by the extravillous trophoblast in the maternal deciduas in early pregnancy. VEGF 
may induce vascular and endometrial cells proliferation and differentiation, as well as be 
involved in the invasion process of embryos implanting into the endometrium. 
 
Cytokines/ Growth factors Enzymes/Tissue mediators 
VEGF - Vascular Endothelial Growth Factor 
EGF - Epidermal Growth Factor 
IGF I and II - Insulin-like Growth Factor I and II 
FGF - Fibroblast Growth Factor 
TGF ǂ and ǃ - Transforming Growth Factor ǂ and ǃ 
Il-1 - Interleukin 1 
Il-6 - Interleukin 6 
Il-11 - Interleukin 11 
LIF - Leukemia Inhibitory Factor  
TNF ǂ - Tumor Necrosis Factor ǂ 
IGFBP-1 - Insulin-like Growth Factor binding protein-1  
CSF-1 - Colony Stimulating Factor 1 
MMP-2 - Metalloproteinase-2 
MMP-9 - Metalloproteinase-9 
TIMPs -Tissue Inhibitors of 
Metalloproteinases  
PGE2 - Prostaglandin E2  
Table 1. Biochemical factors involved in the human embryo implantation. 
Interleukins may also exert an influence on human embryo implantation. The increase of the 
expression of interleukin-1 in endothelial cells of uterine spiral vessels and endometrial 
stroma was observed before implantation. Decidualization of endometrial stromal cells in 
vitro is enhanced by interleukin 11. Interleukins can exert an influence on proper 
endometrial receptivity and could have an important impact on successful semi-allograft 
blastocyst implantation (Paiva et al.,2007; White et al., 2007). The expression of colony 
stimulating factor-1 and leukemia-inhibitory factor (LIF) were also found in human 
endometrium as well as in blastocyst structures. It suggest also their possible role in human 
embryo implantation (Simon et al.,1996). 
Cytokines, chemokines, and growth factors have been still investigated in all tissues 
associated with implantation as well as in embryonic structures. These factors are the 
biochemical tools involved in the implantation process. Their cataloguing process is still 
pending, and their role in consecutive parts of embryo implantation process is still not 
completely understood. Table 1 presents the most important factors involved in the human 
embryo implantation. 
4. The role of uterine contractility in embryo implantation 
What could be the reason of recurrent implantation failure among especially young women 
undergoing IVF treatment, when good quality blastocysts are transferred, in patients with 
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any uterine anatomical anomalies, and with any hormonal disorders? The ideal intrauterine 
conditions that enable implantation include appropriate endometrial status, sufficient 
endometrial blood perfusion and absence of excessive uterine contractions. The contractile 
activity of the pregnant and non-pregnant uterus plays an important role in the human 
reproduction. The stimulation of uterine contractions by estrogens during the follicular 
phase in the non-pregnant uterus, supports transport of spermatozoas from vagina to the 
Fallopian tubes. The absence of the uterine contractility, in response to rising progesterone 
serum level, provides an optimal environment for successful embryo implantation. 
Embryo attachment to the endometrial layer and its invasion require the uterine quiescence 
for implantation (Bulletti & de Ziegler,2005,2006). Implantation failures in IVF cycles when 
good quality embryos are transferred, could be a results of increased uterine contractile 
activity during and after transfer procedure (Fanchin et al.,1998,2001). About 15% of 
embryos could be found in vagina after the transfer procedure, and only 45% of transferred 
embryos could be found in the uterus one hour after the transfer (Poindexter et al.,1986). 
Implantation rate seems to be strictly dependent on the uterine activity during embryo 
transfer. The excessive uterine contractile activity during ET procedure is found in about 
30% of IVF patients. Some investigators  found almost 3 times higher clinical pregnancy 
rates in patients with uterine quiescence, than in women with excessive uterine activity (53% 
and 13%, respectively) (Ayoubi et al.,2003). Ayoubi et al. observed changes in uterine 
contractile activity appearing after ovulation in the spontaneous menstrual cycles and in 
stimulated IVF cycles. Uterine contractile frequency did not differ between studied groups 
of patients on the day of luteinizing hormone surge (5 uterine contractile per 1 minute) and 
hCG administration (5.3 uterine contractile per 1 min). In the normal regular menstrual 
cycle, the uterine quiescence is reached about 4 days after the peak of luteinizing hormone. 
Uterine contractile activity in IVF cycles remained elevated until the 4th day after hCG 
administration, despite of higher serum progesterone levels reached after additive oral or 
vaginal progesterone supplementation. The limit of uterine contractility after exposure to 
vaginal progesterone was established by  Fanchin et al. study (Fanchin et al.,2001) and 
Bulletti et al study (Bulletti & de Ziegler,2006). Seven or less contractions detected during 
five minute intervals in ultrasound measurements were found as uterine quiescence. More 
than 7 contractions detected during five minute intervals were presented as increased 
uterine activity. This excessive uterine activity can be also amplify in stimulated cycles, by 
higher serum concentration of estrogens stimulating uterine contractility. In IVF patients 
uterine activity has declined on the 6th day after human chorionic gonadotropin (hCG) 
administration (Ayoubi et al.,2003). These findings can be explanation to improved 
implantation rate observed after blastocyst transfers. There are many studies confirming the 
highest implantation rate after the transfer of embryos in blastocyst stage (Fauque et 
al.,2007; Zander-Fox et al.,2011; Kallen et al.,2010; Gardner et al.,2000). If the uterine 
contractile frequency decreases at the time of blastocyst transfer in patients with excessively 
expressed uterine activity, the postponing of the embryo transfer procedure could be 
considered in these group of patients during IVF treatment. 
The study by Fanchin et al. (Fanchin et al.,2001) showed the possible influence of decreased 
uterine contractility on the high blastocyst implantation rate. Investigators compared the 
frequency of uterine contractions on the day of hCG administration, on the fourth day after 
hCG and on the 7th days after hCG. The significant decrease in uterine contractions frequency 
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was observed from the day of hCG administration (4.4 uterine contractions per 1 minute), by 
the 4th day after hCG (3.5 uterine contractions per 1 minute), to the 7th day after hCG (1.5 
uterine contractions per 1 minute). The decrease of uterine activity was progressive, and 
reached the lowest frequency on the 7th day, at the time of blastocyst transfers. This uterine 
quiescence can be associated with the higher blastocyst implantation rate, in comparison to 
cleavage embryos. However, the most of embryos are still transferred on the 2nd or the 3rd day 
after fertilization, when the elevated uterine contractile activity is observed. 
There is no still an ideal method for assessing the uterine activity of non-pregnant uterus. 
Cardiotocography, bioimpedance measurement or electromyography, or magnetic 
resonance scanning are restricted to evaluation of the activity of only pregnant uterus. Only 
few methods assessing the uterine activity in non-pregnant uterus were described in the 
literature (Kitlas et al.,2009; Rabotti et al.,2009; Kissler et al.,2004). One of the most sensitive 
method, but unfortunately invasive, is the measurement of changes in intrauterine pressure 
which reflect the uterine contractile activity. 
Kissler et al. (Kissler et al.,2004) tried to evaluate the activity of non-pregnant uterus using 
hysterosalpingoscintigraphy (HSSG). This study was the first one to be designed to 
investigate utero-tubal transport function by HSSG and uterine contractility by intrauterine 
pressure (IUP) measurement. Investigators compared these parameters in 21 patients on the 
same day in the periovulatory phase. In HSSG, the transport function was visualized using 
99m-technetium-marked albumin. In IUP measurement methods, the amplitude and 
frequency of uterine contractions per minute, as well as the basal pressure tone were 
assessed by an intrauterine catheter. In periovulatory phase, the mean value of uterine 
contractions was 3.4 contractions per minute, the mean amplitude was 12.0 mmHg and 
basal pressure was 70.7 mmHg. These two methods positively correlated with uterine 
activity. The IUP measurement using special catheter or hysterosalpingoscintigraphy are 
unfortunately invasive and with many limitations in clinical practice. 
Kitlas et al. (Kitlas et al.,2009) tried to assess synchronization between contractions in 
different topographic regions of the uterus in patients with dysmenorrhea. The authors 
presented four different analytic methods to assess uterine signals: the cross-correlation 
function, the coherence function, the wavelet cross-correlation and the wavelet coherence. 
Spontaneous uterine activity was recorded directly by a dual micro-tip catheter consisted of 
two ultra-miniature pressure sensors. One sensor was placed in the fundus, the other one in 
the cervix. The study showed, that the analysis of synchronization of the uterine 
contractions signals may have a diagnostic value, but this method has never been used to 
assess uterine contractility before embryo transfer. 
A promising technique for uterine contractile activity evaluation could be 
electrohysterography (EHG). The EHG measures the electrical activity from the abdominal 
surface, which triggers the contraction of the uterine muscle. Rabotti et al. studies (Rabotti et 
al.,2009) tried to compare electrohysterography with the measurement of intrauterine 
pressure in pregnant uterus. However, a quantitative estimation of the internal uterine 
pressure by EHG is not available for clinical practice in reproductive medicine, probably 
because of small size of non-pregnant uterus. 
In humans, ethical issues do not allow to use any invasive assessment of uterine 
contractions such as intrauterine pressure measurements, during or after embryo transfer 
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procedure. Consequently, the assessment of uterine activity should be non-invasive. Several 
methods involving transvaginal ultrasonography for assessing endometrial and myometrial 
layer movements have been already described. 
The oldest method for assessing the ultrasound images, which can provide information 
about uterine activity, is the M-mode presentation ultrasound technique (Figure 9). This 
method allows the assessment of low-level image data and thus does not provide additional 
information about the object’s shape or location. Application is limited by a number of 
conditions specific to medical imaging. The M-mode technique has a number of 
disadvantages. This method does not measure the movements of the whole uterus, only the 
upper and lower boundaries present within a user specified intersection. This lack of 
provision becomes significant in cases of exaggerated bowel or respiratory movement that 
may change the location of previously marked gaps in the uterus. The uterus can also move 
forward or backward in relation to the intersection that has been set. Since the method does 
not take into account the whole uterine shape into account, only the boundaries crossing the 
intersection are trackable which can make measurement difficult. Even in ideal conditions 
where the boundaries are clear and easy to track, accurate measurement can still be difficult 
to perform. Similarly, it is also difficult to interpret images where contractility is present, but 
not causing movements of boundaries and influencing only the texture of the endometrium. 
This technique also depends on proper visualization of the uterus which is highly variable 
and influenced by factors such as its retrovert position or filling of the urinary bladder. 
 
Fig. 9. M-mode ultrasound technique for assessing endometrial and myometrial movements. 
Fanchin et al. (Fanchin et al.,1998) proposed a method based on analyzing of a line segment 
of the uterus and video sequence that shows two-dimensional plot using successive frames. 
The horizontal component represents line segment length and the vertical component time. 
Although the method is simple and easy to implement, the prototype clearly demonstrates 
drawbacks. In the presence of a slight increase in the amount of noise or movement of the 
uterus, the method is prone to generating mistakes and does not provide useful information 
about uterine contractility. The method was presented in 1998, and the authors did not 
analyzed any good quality film sequences, which are available now thanks to the progress 
in ultrasound imagining. The method was not found to be an accurate tool for the 
measurement of contractility of non-pregnant uterus. 
There are also some possibilities of pharmacological treatment of excessive uterine activity 
in IVF patients. Oral or vaginal progesterone supplementation, even when acting on uterine 
receptivity, improving endometrial status, presents limited benefits for implantation rates in 
patients with excessive uterine activity. Studies assessing the effectiveness of prostaglandin 
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synthesis inhibitors and ǃ2-adrenoreceptor agonists have shown a positive effect on 
pregnancy rates, but these drugs have failed to enter routine clinical use because of safety 
concerns. 
In randomized control trial, Bernabeu et al. (Bernabeu et al.,2006) analyzed the influence of 
administration of indomethacin on implantation rate in oocyte donation recipients. 
Indomethacin is one of  the non-steroid anti-inflammatory drugs (NSAIDs), which inhibit 
the prostaglandin synthesis. Prostaglandins are synthesized from arachidonic acid by 
cyclooxygenase (COX). Indomethacin blocks the COX enzyme, inhibits the production of 
prostaglandins and reduces or inhibits the uterine contractile activity. Prostaglandins are the 
most important factors stimulating the uterine contractions in non-pregnant uterus. 
Bernabeu et al. (Bernabeu et al., 2006). Oocyte donation is the best model to evaluate the 
determinants of implantation, because of the limitations concerned with the fertilized oocyte 
quality. In the studied group of patients the authors administered 100 mg of indomethacin 
rectally (in three doses every 12 hours) starting on the night prior to transfer. Implantation 
rate was 27.8% in the indomethacin group, and 26.4% in the placebo control group. The 
study did not show significant differences in implantation rate among studied groups of 
patients. 
Moon et al. (Moon et al.,2004) examined the effect of other prostaglandin synthesis inhibitor 
piroxicam on implantation rate in IFV patients. In prospective, randomized double-blind, 
placebo controlled trial the authors compared the effect of piroxicam administered in the 
day of embryo transfer in patients undergoing fresh as well frozen IVF cycles, on 
implantation rate. The piroxicam was chosen from several different NSAIDs for its good 
pharmacological efficacy in clinical relief of primary dysmenorrhea. It is supposed that 
primary dysmenorrea is a disease associated with excessive uterine activity appearing 
during menstruation. In studied group of patients, the authors administered 10 mg of 
piroxicam 1-2 hours before embryo transfer. The study showed that piroxicam increased the 
implantation rate in both fresh and frozen cycles. In fresh cycles, the implantation rate in the 
piroxicam group was 18.7% vs. 8,6% in controlled placebo group. In frozen cycles, the 
implantation rate in patients received piroxicam was also higher than in control group, 
(9.4% and 2.3%, respectively). The investigators observed greater beneficial effect of 
piroxicam in patients under 40 years of age in both fresh and frozen IVF cycles. The results 
confirmed the effectiveness of piroxicam in priming the uterus for embryo implantation. 
Pierzyński et al. (Pierzyński et al.,2007) presented a case report describing the first 
administration of atosiban (oxytocin and vasopressin V1 receptor antagonist) in IVF 
treatment. The authors used intravenous bolus dose of 6.75 mg of atosiban administered one 
hour before embryo transfer and continuing the intravenous infusion of atosiban solution 
up to 2 hours after the ET procedure.  The total dose of administered drug was 37.5 mg. One 
hour before embryo transfer investigators assessed the patient’s uterine activity using 
ultrasound, and detected mean 2.75 contractions per 1 minute during 4 minute ultrasound 
recording. Directly before embryo transfer, one hour after starting atosiban administration, 
the uterine contractility decreased to 1.75 contractions per 1 minute. Two good quality 
blastocyst were transferred to the uterus, without complications. Due to ethical reasons 
detecting the uterine contractility after 2 hours after ET, was not performed. The treatment 
resulted in twin pregnancy, delivered by caesarean section at the 29th week of pregnancy 
because of vaginal bleeding suggesting the placental abruption. The previous preclinical 
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study by the same authors did not present any toxic influence of atosiban on rabbit’s 
embryo development and human sperm motility (Pierzyński et al.,2007). 
Moraloglu et al. (Moraloglu et al.,2010) presented the first prospective, randomized, 
placebo-controlled clinical trial involving the administration the oxytocin antagonists before 
embryo transfer. 180 women undergoing intracytoplasmic sperm injection who had top-
quality embryos were randomly allocated into treatment and control groups. The studied 
patients received intravenous administration of atosiban before embryo transfer with a total 
administered dose of 3.75 mg. In the control group, the patients received placebo. The 
implantation rate per transfer in the atosiban patients was 20.4%, which was significantly 
higher than in the control group 12.6%. The miscarriage rates between studied group 
presented 16.7% in the atosiban patients group and 24.4% in the control group. These results 
indicated that atosiban increases the implantation rate after  embryo transfer procedure. 
These results suggest that the treatment with the oxytocin antagonists before embryo 
transfer could be effective in priming of the uterus for implantation. 
5. The role of endometrial structure 
There are multiple studies that have supported or refuted the relationship between 
endometrial features such as thickness, length or pattern and the implantation rate 
(Bassil,2001; Kovacs et al.,2003; Richter et al.,2007; Zhang et al.,2005; Rinaldi et al.,1996). The 
data regarding the role of endometrial thickness as a predictor of implantation outcomes is 
still controversial. Most of the authors suggested that there is a trigger of endometrial 
thicknesses correlating with a significant reduction in the implantation rate (Bassil,2001; 
Weissman et al.,1999; Rinaldi et al.,1996). Some investigators tried to evaluate the 
endometrial pattern on the day of hCG administration, the day of oocyte retrieval or the day 
of embryo transfer and find some predicting markers of successful embryo implantation 
(Dickey et al.,1992; Rashidi et al.,2005), but the results did not show any statistically 
significant results. Fanchin et al. (Fanchin et al.,2000) proposed the assessment of the 
dynamics of endometrial growth to the triple layer together with endometrial thickness and 
endometrial echogenicity as prognostic markers in IVF treatment. 
In IVF cycles, the prediction of the time of implantation window seems to be more difficult 
than in natural cycles. In stimulated cycles in comparison to natural, the excessive, non-
physiological hormones serum concentrations can be responsible for the different 
biochemical and biophysical changes in endometrium and can have different influence on 
embryo implantation. The endometrial changes in the days preceding the oocyte retrieval 
are important to clarify the impact of endometrial features in the prediction of a successful 
embryo implantation. The progression of the histological transformation of the endometrial 
layer and its receptivity can also differ depending on the type of the COH protocol and the 
doses and kinds of gonadotropins. Hormone dependant endometrial cell proliferation and 
differentiation seem to have an important value in endometrial receptivity and successful 
implantation (Bourgain et al.,2002; Bourgain,2004). The changes to endometrial echogenicity 
and structure are caused by rising progesterone serum levels and determine the 
implantation window (Fanchin et al.,2000; Bourgain et al.,2002). 
The differences between endometrial dating in stimulated and natural cycles were 
presented in Bourgain et al. study (Bourgain et al.,2002). The rapid onset of secretory 
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changes in endometrium was observed in IVF cycles on the day of the oocyte retrieval, 
corresponding to at least the second day after ovulation in natural cycles. These endometrial 
changes in IVF cycles were no longer visible after the second day after the oocyte retrieval 
and could be connected with the rapid increase of serum progesterone concentration 
appearing between the day of hCG administration and the day of oocyte retrieval. The 
implantation rate in IVF cycles seems to be not associated with progesterone serum levels, 
but progesterone can correlate with endometrial printing. The study showed that IVF cycles 
presented a significantly advanced endometrial maturation on the day of the oocyte 
retrieval when compared to natural cycles on the day of ovulation. No pregnancies were 
observed when the endometrial maturation was advanced for more than three days on the 
day of hCG administration. 
Some authors (Kovacs et al.,2003; Richter et al.,2007) reported a significant increase of 
implantation rate observed with increase of endometrial thickness, independent from the 
patients’ age and embryo quality. The mean endometrial thickness was greater in the cycles 
resulting in pregnancy than in the cycles not resulting in pregnancy (11.9 mm, and 11.3 mm 
respectively), but these differences were are not large. Authors also found a significant trend 
presenting a decrease in spontaneous miscarriages with an increase of endometrial 
thickness. Dickey et al. (Dickey et al.,1992) did not find significant differences in the 
pregnancy rate between patients with endometrial thickness of 9-13 mm and 14 mm 
assessed on the day of hCG administration. Weissman et al. (Weissman et al.,1999) 
suggested that the threshold of an endometrial thickness of 14-15mm on the day of hCG 
administration a negative influence on implantation rates. Schild et al. (Schild et al.,2001) 
did not observed pregnancies in patients with an endometrial thickness of more than 15 mm 
on the day of embryo transfer, or more than 16 mm on the day of oocyte retrieval. Other 
investigators (Rinaldi et al.,1996) observed correlations between a minimal endometrial 
thickness of 9- 10 mm and higher implantation rates. Some authors (Kupesic et al.,2001; 
Schild et al.,2001) did not observe successful implantations when the endometrium was 
thinner than 7 mm. 
In the study by Kuć et al. (Kuć et al.,2011), relatively higher implantation rates were 
achieved if the endometrium thickness ranged between 12 and13 mm and at least one good-
quality blastocyst was transferred in a double embryo transfer. The study showed that the 
endometrial thickness on the day of the triple layer appearance in the long GnRH agonist 
protocol and GnRH antagonist protocol was connected with a higher implantation rate. This 
was a first study analysing  the dynamism of endometrial growth to triple layer in three 
different controlled ovarian stimulation protocols. The pregnancy rate in the GnRH 
antagonist protocol was statistically dependent on the time of the appearance of the triple 
layer as well as on the endometrial thickness on the day of the triple layer appearance. In the 
long GnRH agonist protocol only the endometrial thickness on the day of the triple layer 
appearance exerted an influence on the implantation rate. If the time between the first day of 
the appearance of the triple layer and the day of the hCG administration was longer than six 
days, no implantations were observed. The appearance of the triple layer after the 13th day 
of stimulation was connected with the lack of implantations. The time of the appearance of 
the endometrial triple layer in COH cycles can be essential for endometrial dating and 
receptivity, as well as for the implantation window. 
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The monitoring of patients on the day of hCG administration together with the day of ET 
could results in some useful information regarding successful implantation, than on any 
other day of treatment. The assessment of endometrial echogenicity performed at the end of 
the late follicular phase in IVF cycles was tested in search of a prognostic factor for embryo 
implantation (Giannaris et al.,2008; Richter et al.,2007; Schild et al.,2001). Some studies 
presented the hypothesis that endometrial features in the late follicular phase can predict 
the IVF outcomes, especially assessment of endometrial pattern and thickness (Scioscia et 
al.,2009; Giannaris et al.,2008; Richter et al.,2007; Zhang et al.,2005; Kovacs et al.,2003; 
Dietterich et al.,2002). 
 
Fig. 10. Echogenicity of endometrial layer: A – hypoechogenic; B – isoechogenic; C – 
hyperechogenic. 
Some studies showed that the endometrial echogenicity (Figure 10) on the day of hCG 
administration or embryo transfer can be a predictive marker of IVF outcomes (Basir et 
al.,2002; Fanchin et al.,2000). Fanchin et al. (Fanchin et al.,2000) confirmed the influence of 
endometrial echogenicity on the implantation rate. High endometrial echogenicity assessed 
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in ultrasound examination on the day of hCG administration was connected with the lower 
implantation rate, but in this study the endometrial echogenic pattern was not evaluated on 
the day of embryo transfer. The intensity of hyperechogenic transformation observed on the 
day of hCG administration may denote an acceleration of secretory changes in 
endometrium. Premature exposure of the endometrium to progesterone during the 
follicular phase in stimulated cycles can also lead to a faster progression of the endometrial 
echogenicity during the early luteal phase and can be associated with the lower 
implantation rate (Fanchin et al.,2000). The relationship between endometrial echogenicity 
observed during ultrasound examination and implantation rate was presented also in Kuć et 
al. study (Kuć et al.,2011). The hyperechogenic endometrium on the day of hCG 
administration was associated with the low pregnancy rate, but only in patients undergoing 
the long GnRH agonist protocol. 
 Some investigators oppose the role of endometrial echogenicity in predicting the successful 
implantation, and they do not find a positive correlation between endometrial thickness and 
endometrial pattern with implantation rate. The authors claimed that endometrial growth 
and its pattern during the controlled ovarian hyperstimulation did not influence on the 
implantation rate (Bassil,2001; Kupesic et al.,2001; Rashidi et al.,2005). 
Zhang et al. (Zhang et al.,2005) showed a significant correlation between the endometrial 
thickness, the length of gonadotropins administration and their influence on implantation 
rates. Controlled ovarian hyperstimulation last longer than 11 days corresponded with 
thinner endometrium and lower implantation rate. Authors also suggested that in some 
groups of patients, the implantation rate can depend on the endometrial thickness, and the 
implantation rate was statistically unaffected by endometrial thickness when good-quality 
embryos were transferred. 
 Endometrial parameters could be helpful predictors of the successful implantation, but they 
should be analyzed in a multivariate analysis rather than used alone. The most precise 
evaluation of the impact that endometrial features have on the implantation rate should be 
carried out on patients with a single, high quality blastocyst transfer. 
6. Conclusions 
In conclusions, successful embryo implantation requires a genetically and morphologically 
healthy embryo as well as developed receptive endometrium. The interactions between the 
embryo and endometrial layer during implantation have been not still completely understood. 
Nowadays, most of investigators recommend single blastocyst transfer on the 5th day after OR, 
if sufficient number of good quality embryos is cultured on the 3rd day. Uterine contractions at 
the time of embryo transfer negatively affect embryo implantation, but the methods for 
assessing uterine activity are not sensitive enough. The constant progress in biomedical 
sciences allows in the future finding the new markers dating endometrial receptivity, and 
implantation window, as well as better selection of the cultured embryos. 
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